- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 345
Facebook likes Fayteq
Fayteq, a real-time video editing technology developer spun out of TU Ilmenau, has been acquired by Facebook for an undisclosed sum.
Aug 15, 2017Unomy goes to WeWork
WeWork has paid an undisclosed amount to acquire sales and marketing intelligence software provider Unomy, allowing Leta Capital to exit.
Aug 14, 2017Wantedly wanders toward public markets
The CyberAgent and Nihon Keizai Shimbun-backed recruitment and networking platform developer is set to float in its home country of Japan next month.
Aug 14, 2017Walmart enters talks to pick up Birchbox
Birchbox, the beauty product subscription service that has raised $87m in financing from backers such as Comcast, has reportedly begun talks with retailers including Walmart over an acquisition.
Aug 11, 2017Iheima hits public markets
Iheima has raised $27.3m in its initial public offering, becoming the first incubator to float in China and providing an exit to corporate investors Toread and Youyou.
Aug 10, 2017Disney dives further into BamTech with $1.58bn
Walt Disney Company has followed its $1bn investment in online streaming technology provider BamTech by upping its stake to 75% as it prepares to launch its own streaming service.
Aug 10, 2017Nielsen tracks down vBrand for acquisition
Nielsen has bought Nielsen Innovate graduate vBrand and will integrate the company's sport sponsorship tracking technology into its sports media offering.
Aug 7, 2017Big Deal: Bristol-Myers Squibb tunes into IFM
The pharmaceutical company's acquisition of Novartis-backed IFM Therapeutics, consisting of $300m upfront and up to $2bn in milestone payments, is its fourth purchase of a CVC-backed company in under four years.
Aug 7, 2017Intelesens connects to Ultralinq
Ultralinq has acquired Intelesens, a wearable device manufacturer spun out from Ulster University in 2001.
Aug 4, 2017Clementia cleaves $120m from IPO
UCB Pharma scored an exit after the bone disease therapy developer floated at the top of its range, having secured $92.5m in funding over the past two years.
Aug 3, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


